Beximco Pharmaceuticals Ltd.
Beximco Pharma celebrates its launching of vision unit & ophthalmic range
Beximco Pharmaceuticals Ltd. (BPL or the Company), the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh celebrated its newly launched ophthalmic division named “Beximco Pharma Vision” with the Ophthalmologist community of the country on October 30, 2009 at Dhaka.
Beximco Pharma Vision uses the most modern equipment for quality control and stringent quality assurance procedure to ensure highest quality of eye products. Beximco Pharma Vision’s manufacturing process conforms strictly to the current Good Manufacturing Practices (cGMP) to produce world class ophthalmic products. This division has so far launched 10 eye care brands and in addition to these brands a number of much needed products will be introduced in the coming months to cater to the need of eye specialists.
On the occasion of launching ophthalmic products, Beximco Pharma Managing Director Mr. Nazmul Hassan said, “From its very inception, Beximco Pharma has been a technology driven pharmaceutical company and has always been pioneer in introducing new high-tech formulations in Bangladesh. BPL was the first company in Bangladesh to introduce high-tech Intravenous fluids with auto-collapsible bottle using state-of-the-art Form-Fill-Seal technology, MDI technology and is also the first to switch to CFC-free advanced echnology HFA based MDIs. BPL’s Chief Operating Officer, Mr. Rabbur Reza said, its our findings that though we have a good number of ophthalmic products in the market, we still have to import a good number of echnology-driven products from abroad, because these products have definite demand for eye patients of the country. That’s why while launching our vision unit and ophthalmic products, we have planned to offer the whole range of technology-driven ophthalmic products as well as the regularly needed products so that world class eye products can be made available at an affordable price for the patients by mid of 2010.”
Prof. Syed Modasser Ali was the Chief Guest of the program while Prof. (Dr.) Ava Hossain, Dr. Deen Mohd. Noorul Huq and Dr. Md. Sharfuddin Ahmed were also present as guests.
About Beximco Pharmaceuticals Limited
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.
The Company’s products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.
Beximco Pharma is the only Bangladeshi company to receive GMP Certification from Gulf Central Committee for Drug Registration, Executive Board of the Health Ministers' Council for GCC states and first Bangladeshi company to receive GMP Clearance from Therapeutic Goods Administration (TGA), Australia and National Health Surveillance Agency (ANVISA), Brazil